ArticleEJNMMI radiopharmacy and chemistry2021
Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.
Article in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- ExpandingEJNMMI radiopharmacy and chemistry · 2026Article
- Evaluation of Cyclotron Solid Target Produced Gallium-68 Chloride for the Labeling of [Molecules (Basel, Switzerland) · 2025Article
- Review
- [Current radiopharmaceuticals · 2025Article
- A comparison of routine [EJNMMI radiopharmacy and chemistry · 2024Article
- Advances in Radioligand Theranostics in Oncology.Molecular diagnosis & therapy · 2024Review
- Optimization and scale up of production of the PSMA imaging agent [EJNMMI radiopharmacy and chemistry · 2024Article
- Fully automated radiosynthesis of [EJNMMI radiopharmacy and chemistry · 2023Article
- Article
- Cyclotron Production of Gallium-68 Radiopharmaceuticals Using thePharmaceutics · 2022Review
- Recovery of Gallium-68 and Zinc from HNOMolecules (Basel, Switzerland) · 2022Article
- Good practices forEJNMMI radiopharmacy and chemistry · 2022Review
- Preparation and Evaluation of [Molecules (Basel, Switzerland) · 2022Article
- Analysis of Pros and Cons in Using [Molecules (Basel, Switzerland) · 2022Article
- Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Article
- Methods for the Determination of Transition Metal Impurities in Cyclotron-Produced Radiometals.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Automated light-induced synthesis ofScientific reports · 2022Article
- Cold Kit Labeling: The Future ofFrontiers in medicine · 2022Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith increasing clinical demand for gallium-68, commercial germanium-68/gallium-68 ([
resultsEnriched zinc-68 targets were irradiated at up to 80 µA with 13 MeV protons for 120 min; repeatedly producing up to 194 GBq (5.24 Ci) of purified gallium-68 in the form of [
conclusionsWe have developed a high-yielding, automated method for the production of very high amounts of [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.